secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solid Biosciences Inc. (SLDB)
CIK:        0001707502
Form:       8-K
Filed at:   2025-02-18T23:59:59+00:00
Accession:  0001193125-25-028146
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Solid Biosciences prices $200M underwritten offering; extends cash runway into first half 2027
--------------------------------------------------------------------------------

- Priced $200M underwritten offering expected to close Feb 19, 2025; net proceeds to fund R&D for SGT-003 and other candidates.
- Company estimates cash runway into first half of 2027, but notes offering alone may not fully fund development of all candidates.
- Remaining proceeds for general corporate purposes; existing cash and securities combined for operating plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1707502/000119312525028146/0001193125-25-028146-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1707502/000119312525028146/d916580d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-028146

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer